Astra wins EU orphan drug status for cancer drug
557746
AstraZeneca Plc's experimental cancer drug AZD2281 has been given orphan drug status by the European Medicines Agency for treating women with ovarian cancer, Britain's second biggest drugmaker said on Tuesday.
758098
German drugmaker Schering AG said on  Thursday that the U.S. Food and Drug Administration had granted  its breast cancer treatment bonefos "priority review" status.
653679
The EU market welcomes the drugmaker's copy of a treatment for anemia.
510674
NEW YORK, November 19  - Tarceva, an experimental lung cancer drug, has been approved by the Food &amp; Drug Administration, Genentech (DNA.
480028
Indianapolis, November 1 (ots/PRNewswire) - New data presented today confirm that advanced lung cancer patients can look forward to better-quality survival when treated with Alimta(R) (pemetrexed), a newly approved anticancer agent in the European Union
421575
Genentech and OSI Pharmaceuticals won federal approval yesterday to sell Tarceva, a pill to treat lung cancer. The approval by the Food and Drug Administration came well before the agency&#39;s
602931
US drug regulators approved Tuesday the targeted anti-cancer treatment Tykerb (lapatinib) for use together with another drug, Xeloda (capectabine) in certain advanced breast cancers.
191337
GlaxoSmithKline won permission yesterday from the Food and Drug Administration to sell a tumor-growth inhibitor called Tykerb to treat breast cancer.
394537
A breakthrough cancer drug made by a Long Island company won federal approval late Thursday in a major victory for cancer patients and the region&#39;s budding biotech industry.
320147
Cancer drug shows exceptional promise as it moves toward FDA review.
13123
UK biotechnology company Cambridge Antibody Technology has announced a five-year alliance with pharmaceutical giant AstraZeneca. CAT said AstraZeneca will make an upfront equity investment in CAT worth Â£75
518382
A new drug that fights a form of age-related macular degeneration (AMD), a leading cause of blindness in the elderly, won applause if not approval from a panel of advisors to the US Food and Drug Administration.
177864
German drugmaker Schering AG said on Thursday that the U.S. Food and Drug Administration had granted its breast cancer treatment bonefos "priority review" status.
410925
An experimental treatment for brain cancer has won approval for commercial use in Switzerland, its London-listed US maker, Northwest Biotherapeutics, Inc., announced on Monday.
368066
The US drug agency agreed to allow a drug currently used against advanced breast cancer to be prescribed to prevent the disease from recurring in women who have been treated for early forms of the disease.
711508
MADISON, NJ - Pharmaceutical firm Wyeth said Tuesday that the Food and Drug Administration (news - web sites) granted fast-track status to its experimental cancer drug temsirolimus as an initial treatment for patients with advanced kidney cancer.
564304
WASHINGTON/LONDON  - An FDA review AstraZeneca  Plc's  under the name Coumadin.